Results showed that Emblaveo had similar cure rates compared with meropenem for treating complicated intra-abdominal infections (76.4% vs 74%). Emblaveo also showed lower mortality rates with no ...

The FDA has approved the intravenous antibiotic Emblaveo for adults with complicated intra-abdominal infections who have limited treatment options. Emblaveo (aztreonam and avibactam), is the first ...

Feb 7 (Reuters) - AbbVie (ABBV.N), opens new tab said on Friday that the U.S. Food and Drug Administration approved its drug for complicated intra-abdominal infections, including those caused by ...

This randomized, open-label trial evaluated aztreonam-avibactam plus metronidazole versus meropenem with or without colistin in patients with complicated intra-abdominal infections, or hospital ...

In combination with metronidazole, Emblaveo is approved for patients aged 18 and older who have limited or no alternative options for treating complicated intra-abdominal infections (cIAI).

Severe outbreaks of the flu, COVID-19, RSV and norovirus are occurring throughout the United States, especially in areas where there are lower vaccination rates. “This year, we’ve seen earlier ...

Some of the best stomach exercises ... body and reach under the space between your chest and the ground. Twist only from the waist up. Come back up, then repeat four times. Lower your body to ...

Our investment management business generates asset-based fees, which are calculated as a percentage of assets under management. We also sell both admissions and sponsorship packages for our ...

Approval of this indication is based on limited clinical safety and efficacy data for Emblaveo. In REVISIT, study participants with cIAI (n=312) were randomly assigned 2:1 to receive ...

“If we see further disinflation and rising unemployment, it could accelerate rate cuts and lower mortgage rates. However, resilient economic data could keep rates elevated.” “An average of ...